Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Still's Disease, Juvenile-Onset”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableUnknownNCT03651193
What this trial is testing

Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population

Who this might be right for
Adult Onset Still Disease
Second Xiangya Hospital of Central South University 150
Not applicableStudy completedNCT03276650
What this trial is testing

Admission of Adult-onset Still Disease Patients in the ICU

Who this might be right for
Adult-Onset Still DiseaseCritically Ill
Central Hospital, Nancy, France 45
Not applicableStudy completedNCT03932344
What this trial is testing

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Still Disease, Juvenile Onset
Swedish Orphan Biovitrum 306
Testing effectiveness (Phase 2)Study completedNCT01033656
What this trial is testing

Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study

Who this might be right for
Adult-Onset Still's Disease
University of Helsinki 23
Not applicableLooking for participantsNCT03510442
What this trial is testing

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

Who this might be right for
Still's Disease, Adult-OnsetSystemic InflammationArthritis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Testing effectiveness (Phase 2)Study completedNCT02398435
What this trial is testing

Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease

Who this might be right for
Still's Disease, Adult-Onset
AB2 Bio Ltd. 23
Testing effectiveness (Phase 2)Ended earlyNCT02204293
What this trial is testing

Canakinumab for Treatment of Adult-onset Still's Disease

Who this might be right for
Adult-Onset Still´s Disease
Charite University, Berlin, Germany 36
Early research (Phase 1)Study completedNCT05715736
What this trial is testing

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3

Who this might be right for
Still's Disease, Adult-Onset
Syneos Health 31
Not applicableLooking for participantsNCT05927454
What this trial is testing

Acostill ( RaDiCo Cohort) (RaDiCo Acostill)

Who this might be right for
Still DiseaseStill's Disease, Adult-OnsetStill Disease, Juvenile Onset
Institut National de la Santé Et de la Recherche Médicale, France 500
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Not applicableStudy completedNCT06992505
What this trial is testing

Assessment of Macrophage Activation syndromE in STill's Disease in Italy

Who this might be right for
Macrophage Activation Syndrome (MAS)Still Disease, Juvenile OnsetStill's Disease, Adult-Onset
Swedish Orphan Biovitrum 32
Early research (Phase 1)Ended earlyNCT04752371
What this trial is testing

Evaluate Camoteskimab in Participants With Still's Disease

Who this might be right for
Adult Onset Still's Disease
Apollo Therapeutics Ltd 5
Large-scale testing (Phase 3)Ended earlyNCT03265132
What this trial is testing

Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Adult-OnsetStill's Disease, Juvenile-Onset
Swedish Orphan Biovitrum 13
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Testing effectiveness (Phase 2)Study completedNCT03311854
What this trial is testing

Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more
Swedish Orphan Biovitrum 14
Large-scale testing (Phase 3)Active Not RecruitingNCT05814159
What this trial is testing

Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Juvenile OnsetStill's Disease, Adult-Onset
Swedish Orphan Biovitrum 15
Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Not applicableNot Yet RecruitingNCT07191444
What this trial is testing

Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Who this might be right for
Still's Disease, Adult-Onset
Ruijin Hospital 20
Not applicableLooking for participantsNCT06339177
What this trial is testing

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Who this might be right for
Lymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation Syndrome+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Study completedNCT00094900
What this trial is testing

Interleukin-1 Trap to Treat Autoinflammatory Diseases

Who this might be right for
InflammationFamilial Mediterranean FeverStill's Disease, Adult-Onset
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 11
Load More Results